GPT and Thrombocytopenia: Of the three DLTs occurring in the two patients in the berzosertib 72 mg/m2 + gemcitabine 875 mg/m2 cohort, one patient had two DLTs (grade 3-increased ALT and grade 3 fatigue) and another patient had a DLT of grade 4 thrombocytopenia.